Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19

Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern

(2022) Paul R. Wratil et al.   NATURE MEDICINE

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

(2022) Sabine Haggenburg et al.   Blood Advances

Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study

(2021) Julia Hippisley-Cox et al.   BMJ-British Medical Journal

Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study

(2021) Kazimieras Maneikis et al.   Lancet Haematology

Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease

(2021) Thomas A. Ollila et al.   JAMA Oncology

Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination

(2021) Tom G. Caniels et al.   Science Advances

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination

(2021) Yair Herishanu et al.   BLOOD

mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial

(2021) Sjoukje F Oosting et al.   LANCET ONCOLOGY

The RECOVAC Immune-response Study

(2021) Jan-Stephan F. Sanders et al.   TRANSPLANTATION

Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia

(2021) Alessandro Allegra et al.   Frontiers in Immunology

SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence

(2020) Gerco den Hartog et al.   JOURNAL OF INFECTIOUS DISEASES

Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL)

(2020) Francesca Romana Mauro et al.   LEUKEMIA